These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 37932511)

  • 1. Role of the microbiota in response to and recovery from cancer therapy.
    Blake SJ; Wolf Y; Boursi B; Lynn DJ
    Nat Rev Immunol; 2024 May; 24(5):308-325. PubMed ID: 37932511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
    Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
    Front Immunol; 2021; 12():669150. PubMed ID: 34267748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the gut microbiota in tumor, immunity, and immunotherapy.
    Xie Y; Liu F
    Front Immunol; 2024; 15():1410928. PubMed ID: 38903520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota in Cancer Immune Response and Immunotherapy.
    Zhou CB; Zhou YL; Fang JY
    Trends Cancer; 2021 Jul; 7(7):647-660. PubMed ID: 33674230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new biological triangle in cancer: intestinal microbiota, immune checkpoint inhibitors and antibiotics.
    Zhang J; Dai Z; Yan C; Zhang W; Wang D; Tang D
    Clin Transl Oncol; 2021 Dec; 23(12):2415-2430. PubMed ID: 34125407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and Challenges.
    Bouferraa Y; Chedid A; Amhaz G; El Lakkiss A; Mukherji D; Temraz S; Shamseddine A
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A viable remedy for overcoming resistance to anti-PD-1 immunotherapy: Fecal microbiota transplantation.
    Meng Y; Sun J; Zhang G
    Crit Rev Oncol Hematol; 2024 Aug; 200():104403. PubMed ID: 38838927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of modulating the gastrointestinal microbiota in cancer patients.
    Morkūnas E; Skiecevičienė J; Kupčinskas J
    Best Pract Res Clin Gastroenterol; 2020; 48-49():101700. PubMed ID: 33317795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiota Manipulated to Enhance Immunity.
    Cancer Discov; 2019 Jul; 9(7):822. PubMed ID: 31072874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.
    Matson V; Chervin CS; Gajewski TF
    Gastroenterology; 2021 Jan; 160(2):600-613. PubMed ID: 33253684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex interactions between the microbiome and cancer immune therapy.
    Schwartz DJ; Rebeck ON; Dantas G
    Crit Rev Clin Lab Sci; 2019 Dec; 56(8):567-585. PubMed ID: 31526274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From poo to promise: Fecal microbiota transplants support immunotherapy re-sensitization in solid tumors.
    Chambers L; Grencewicz D; Spakowicz D
    Cell Host Microbe; 2024 Aug; 32(8):1217-1218. PubMed ID: 39146792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.
    Rezasoltani S; Yadegar A; Asadzadeh Aghdaei H; Reza Zali M
    Cancer Med; 2021 Feb; 10(3):1141-1154. PubMed ID: 33369247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiome and cancer treatment: Are we ready to apply in clinics?
    Chan SL
    Prog Mol Biol Transl Sci; 2020; 171():301-308. PubMed ID: 32475526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiome and cancer immunotherapy.
    Li W; Deng Y; Chu Q; Zhang P
    Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intratumoral microbiota: a new horizon in cancer immunology.
    Liu W; Li Y; Wu P; Guo X; Xu Y; Jin L; Zhao D
    Front Cell Infect Microbiol; 2024; 14():1409464. PubMed ID: 39135638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiome Modulation Via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers.
    McQuade JL; Ologun GO; Arora R; Wargo JA
    Curr Oncol Rep; 2020 Jun; 22(7):74. PubMed ID: 32577835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulation by the Commensal Microbiome During Immune-Targeted Interventions: Focus on Cancer Immune Checkpoint Inhibitor Therapy and Vaccination.
    Reens AL; Cabral DJ; Liang X; Norton JE; Therien AG; Hazuda DJ; Swaminathan G
    Front Immunol; 2021; 12():643255. PubMed ID: 34054810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards enhancing the predictive value of the microbiota for cancer immunotherapy.
    Dzutsev AK; Goldszmid RS
    Trends Cancer; 2024 Sep; 10(9):771-773. PubMed ID: 39089931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between intestinal microbiota and tumour immunity in the tumour microenvironment.
    Yang X; Guo Y; Chen C; Shao B; Zhao L; Zhou Q; Liu J; Wang G; Yuan W; Sun Z
    Immunology; 2021 Nov; 164(3):476-493. PubMed ID: 34322877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.